Toronto-based Braxia Scientific awarded nearly $1 million to study ketamine with cognitive behavioural therapy to reduce suicidality

Growth op

“In addition to offering rapid and significant symptom relief in adults with depression, ketamine has also demonstrated rapid reductions in suicidality in people with depression.”

Excerpt only …
READ MORE BELOW
Source : Toronto-based Braxia Scientific awarded nearly million to study ketamine with cognitive behavioural therapy to reduce suicidality

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.